Medindia

X

The Advisory Board Company to Present at Upcoming Conferences

Thursday, May 19, 2011 General News J E 4
Advertisement


WASHINGTON, May 18, 2011 The Advisory Board Company (NASDAQ: ABCO) announced today that Robert W. Musslewhite, Chief Executive Officer, and Michael T. Kirshbaum, Chief Financial Officer are scheduled for presentations at two upcoming investor conferences.

Mr. Musslewhite and Mr. Kirshbaum are scheduled to present on Wednesday, June 8, 2011 at 8:00 AM EDT at the Jefferies 2011 Global Healthcare Conference in New York, New York.

Mr. Musslewhite and Mr. Kirshbaum are scheduled to present on Wednesday, June 15, 2011 at 3:20 PM CDT at the William Blair 31st Annual Growth Stock Conference in Chicago, Illinois.

The presentation materials will be available on the Company's web site, found at www.advisoryboardcompany.com through June 30, 2011.

About The Advisory Board Company

The Advisory Board Company provides best practices research and analysis, business intelligence and software tools, and installation support and management and advisory services to approximately 3,200 organizations, including hospitals, health systems, pharmaceutical and biotech companies, health care insurers, medical device companies, colleges, universities, and other educational institutions. Members of each program typically are charged a fixed fee and have access to an integrated set of services that may include best practice research studies, executive education seminars, customized research briefs, web-based access to the program's content database, and software tools.

SOURCE The Advisory Board Company
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Universal Health Services, Inc. Announces Dividend
S
CitiusTech's BI-Clinical Framework 10.3 Receives O...